Key result
US minority populations face significant disparities in HF epidemiology, management, advanced therapy access, and outcomes.
Why the study?
Heart failure disproportionately impacts minority groups in the United States, with persistent disparities in treatment, advanced therapies, and outcomes that clinical practice guidelines and trials fail to address.
Highlights significant disparities in heart failure care and outcomes among minority populations in the US, emphasizing the need for tailored interventions.
Supports equity-focused heart failure strategies; leaves open optimal interventions pending prospective trials.
Heart failure (HF) disproportionately impacts minority groups in the United States. Among minorities living with HF, disparities exist in treatment, access to advanced therapies such as durable left ventricular assist devices and heart transplantation, and outcomes. Reasons for observed disparities range from the prevalence of traditional cardiovascular risk factors to social determinants of health, including housing, access to healthcare, and socioeconomic status. Clinical practice guidelines frequently are unable to address these observed disparities, and clinical trials often underrepresent minority populations. Custom programs tailored toward addressing disparities in HF care are needed to help improve outcomes in minority populations.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) conducted a review in Heart failure. Minority populations in the United States experience significant disparities in heart failure epidemiology, management, access to advanced therapies, and clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: